Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Paal W. Wallace - , Technische Universität Dresden (Autor:in)
  • Catleen Conrad - , Technische Universität Dresden (Autor:in)
  • Sascha Brückmann - , Technische Universität Dresden (Autor:in)
  • Ying Pang - , National Institutes of Health (NIH) (Autor:in)
  • Eduardo Caleiras - , Instituto de Salud Carlos III (Autor:in)
  • Masanori Murakami - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Esther Korpershoek - , Erasmus University Rotterdam (Autor:in)
  • Zhengping Zhuang - , National Institutes of Health (NIH) (Autor:in)
  • Elena Rapizzi - , Università degli Studi di Firenze (Autor:in)
  • Matthias Kroiss - , Julius-Maximilians-Universität Würzburg (Autor:in)
  • Volker Gudziol - , Technische Universität Dresden (Autor:in)
  • Henri J.L.M. Timmers - , Radboud University Nijmegen (Autor:in)
  • Massimo Mannelli - , Università degli Studi di Firenze (Autor:in)
  • Jens Pietzsch - , Helmholtz-Zentrum Dresden-Rossendorf, Technische Universität Dresden (Autor:in)
  • Felix Beuschlein - , Ludwig-Maximilians-Universität München (LMU), University of Zurich (Autor:in)
  • Karel Pacak - , National Institutes of Health (NIH) (Autor:in)
  • Mercedes Robledo - , CIBER - Center for Biomedical Research Network (Autor:in)
  • Barbara Klink - , Technische Universität Dresden, Laboratoire National de Santé (Autor:in)
  • Mirko Peitzsch - , Institut für Klinische Chemie und Laboratoriumsmedizin (Autor:in)
  • Anthony J. Gill - , Royal North Shore Hospital, University of Sydney (Autor:in)
  • Arthur S. Tischler - , Tufts University (Autor:in)
  • Ronald R. de Krijger - , Utrecht University, Princess Máxima Center for Pediatric Oncology (Autor:in)
  • Thomas Papathomas - , University of Birmingham (Autor:in)
  • Daniela Aust - , Institut für Pathologie (Autor:in)
  • Graeme Eisenhofer - , Medizinische Klinik und Poliklinik 3 (Autor:in)
  • Susan Richter - , Institut für Klinische Chemie und Laboratoriumsmedizin (Autor:in)

Abstract

Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours with a hereditary background in over one-third of patients. Mutations in succinate dehydrogenase (SDH) genes increase the risk for PPGLs and several other tumours. Mutations in subunit B (SDHB) in particular are a risk factor for metastatic disease, further highlighting the importance of identifying SDHx mutations for patient management. Genetic variants of unknown significance, where implications for the patient and family members are unclear, are a problem for interpretation. For such cases, reliable methods for evaluating protein functionality are required. Immunohistochemistry for SDHB (SDHB-IHC) is the method of choice but does not assess functionality at the enzymatic level. Liquid chromatography–mass spectrometry-based measurements of metabolite precursors and products of enzymatic reactions provide an alternative method. Here, we compare SDHB-IHC with metabolite profiling in 189 tumours from 187 PPGL patients. Besides evaluating succinate:fumarate ratios (SFRs), machine learning algorithms were developed to establish predictive models for interpreting metabolite data. Metabolite profiling showed higher diagnostic specificity compared to SDHB-IHC (99.2% versus 92.5%, p = 0.021), whereas sensitivity was comparable. Application of machine learning algorithms to metabolite profiles improved predictive ability over that of the SFR, in particular for hard-to-interpret cases of head and neck paragangliomas (AUC 0.9821 versus 0.9613, p = 0.044). Importantly, the combination of metabolite profiling with SDHB-IHC has complementary utility, as SDHB-IHC correctly classified all but one of the false negatives from metabolite profiling strategies, while metabolite profiling correctly classified all but one of the false negatives/positives from SDHB-IHC. From 186 tumours with confirmed status of SDHx variant pathogenicity, the combination of the two methods resulted in 185 correct predictions, highlighting the benefits of both strategies for patient management.

Details

OriginalspracheEnglisch
Seiten (von - bis)378-387
Seitenumfang10
FachzeitschriftJournal of pathology
Jahrgang251
Ausgabenummer4
PublikationsstatusVeröffentlicht - 1 Aug. 2020
Peer-Review-StatusJa

Externe IDs

PubMed 32462735
ORCID /0000-0002-3549-2477/work/142244880

Schlagworte

ASJC Scopus Sachgebiete

Schlagwörter

  • diagnostics, Krebs cycle metabolites, LC–MS/MS, linear discriminant analysis, mass spectrometry, metabolite profiling, multi-observer, prediction models, succinate to fumarate ratio, variants of unknown significance